Does Tecovirimat Monohydrate Interact with Sucroferric Oxyhydroxide?
Tecovirimat Monohydrate and Sucroferric Oxyhydroxide have a moderate drug interaction according to U.S. FDA drug labeling data. Phosphate binder increases tecovirimat bioavailability. Monitor for signs or symptoms of adverse effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Tecovirimat Monohydrate Class
- Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor
- Sucroferric Oxyhydroxide Class
- Phosphate Binder
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
What To Tell Your Doctor or Pharmacist
If you are taking Tecovirimat Monohydrate and your doctor is considering prescribing Sucroferric Oxyhydroxide (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider